Net Loss per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Numerator:
Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders, basic	$ (892,869)	$ (2,104,929)	$ (1,830,047)
Less: change in fair value of warrant liabilities	0	0	58,615
Less: change in fair value of contingent consideration common shares liability	0	3,143	0
Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders, diluted	$ (892,869)	$ (2,108,072)	$ (1,888,662)
Denominator
Basic (in shares)	1,944,420,000	1,679,061,000	1,359,849,000
Effect of dilutive securities:
Warrants (in shares)	0	0	525,000
Contingent consideration common shares (in shares)	0	777,000	0
Weighted average common shares outstanding, diluted (in shares)	1,944,420,000	1,679,839,000	1,360,373,000
Basic (in dollars per share)	$ (0.46)	$ (1.25)	$ (1.35)
Diluted (in dollars per share)	$ (0.46)	$ (1.25)	$ (1.39)